| Contact Details | 4th FL, 15, Seolleung-ro 121-gil, Gangnam-gu, Seoul 82-2-540-5630contact@neuroventi.com |
|---|
NeuroVenti
Category:
Venture
Main Business Area
NeuroVenti is a company that focuses on the development of neuroprotective and therapeutic agents against neuronal disorders. They have successfully obtained FDA orphan drug designation for their autism treatment candidate (NV01-A02) and are currently preparing for phase 2 clinical trials in Korea.
